상세 보기
Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma (R)) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+metastatic breast cancer (KCSG BR 18-14/KM10B)
- Sim, Sung Hoon;
- Kim, Jeong Eun;
- Kim, Min Hwan;
- Park, Yeon Hee;
- Kim, Jee Hyun;
- ... Park, In Hae;
- 외 16명
Citations
WEB OF SCIENCE
2Citations
SCOPUS
3초록
We investigated the efficacy and safety of a trastuzumab biosimilar, Herzuma (R), in combination with treatment of physician's choice (TPC) in patients with HER2+ metastatic breast cancer (MBC) who had failed at least two HER2 directed chemotherapies.
키워드
HER2 positive; Metastatic breast cancer; Trastuzumab biosimilar; Clinical trial; ctDNA; DOUBLE-BLIND; PROGRESSION; RETREATMENT; GUIDELINE; MUTATIONS; EMTANSINE; LAPATINIB; HER2
- 제목
- Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma (R)) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+metastatic breast cancer (KCSG BR 18-14/KM10B)
- 저자
- Sim, Sung Hoon; Kim, Jeong Eun; Kim, Min Hwan; Park, Yeon Hee; Kim, Jee Hyun; Suh, Koung Jin; Koh, Su-Jin; Park, Kyong Hwa; Kang, Myoung Joo; Ahn, Mi Sun; Lee, Kyoung Eun; Kim, Hee -Jun; Ahn, Hee Kyung; Kim, Han Jo; Park, Keon Uk; Byun, Jae Ho; Park, Jin Hyun; Lee, Gyeong-Won; Lee, Keun Seok; Sohn, Joohyuk; Jung, Kyung Hae; Park, In Hae
- 발행일
- 2022-10
- 유형
- Article
- 저널명
- Breast
- 권
- 65
- 페이지
- 172 ~ 178